Biobeat Raises $50 Million Series B to Expand Cuff-less Blood Pressure Monitor

Jan 7, 2026
Biobeat Technologies has raised $50 million in Series B funding led by Ally Bridge Group, OrbiMed Advisors, and Elevage Medical to expand commercialization of its FDA-cleared, cuff-less 24-hour ambulatory blood pressure monitoring system in the U.S.

Biobeat Technologies has raised $50 million in Series B equity financing to advance commercialization of its FDA-cleared, cuff-less 24-hour ambulatory blood pressure monitoring system, announced in a press release. The funding round was led by new investors Ally Bridge Group, OrbiMed Advisors, and Elevage Medical, with participation from a strategic investor.

The proceeds will be used to expand Biobeat’s U.S. commercial operations. The company’s patch-worn device enables continuous ambulatory blood pressure monitoring without the need for a traditional cuff, allowing patients to maintain normal daily activities and sleep undisturbed. After monitoring, the disposable patch automatically generates a report integrated into the institution’s electronic medical records.

The financing also brings new members to Biobeat’s board of directors, including representatives from Ally Bridge, OrbiMed, and Elevage. The company operates from Tel Aviv, Israel, and Boca Raton, Florida, and aims to make 24-hour ambulatory blood pressure monitoring a standard of care for hypertension management.

We hope you enjoyed this article

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.